A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2001
11/15/2001	US20010041720 2-Amino-N-((1R)-2-((3R)-3-benzyl-3-(N,N',N' -trimethylhydrazinocarbonyl)piperidin-1-yl)-1-(1H-indol-3-ylmethyl)-2 -oxoethyl)-2-methylpropionamide; increasing rate and extent of growth, milk and wool production
11/15/2001	US20010041710 (4R)-1-(4-(4-Fluorophenoxy)benzyl)-2-oxo-imidazolidine-4 -carboxylic acid hydroxyamide, for example; treating various diseases including osteoarthritis, rheumatoid arthritis, cancer, osteoporosis, strokes
11/15/2001	US20010041700 A carbamoyl or S=C(NH) group containing nitrile derivatives, useful as cysteine protease inhibitor
11/15/2001	US20010041681 Therapeutically useful synthetic oligonucleotides
11/15/2001	US20010041671 Ophthalmic formulations
11/15/2001	US20010041191 Magnesium lactate, magnesium asparate, magnesium acetate, magnesium pyrophosphate
11/15/2001	US20010041180 Substantially non-toxic biologically active mucosal adjuvants in vertebrate subjects
11/15/2001	US20010041179 Immunosuppression with monoclonal antibodies specific for interleukin-2 receptor
11/15/2001	US20010041178 Preventing airway mucus production by administration of EGF-R antagonists
11/15/2001	DE10022925A1 New indole-carboxamide or azepino-indole derivatives and analogs, are poly-ADP ribose polymerase inhibitors useful e.g. for treating neurodegenerative disease, ischemia, epilepsy, tumors, sepsis or diabetes mellitus
11/15/2001	CA2776904A1 A device for forming or increasing the number of undifferentiated cells
11/15/2001	CA2409759A1 Method and composition for the treatment of angiogenesis
11/15/2001	CA2408935A1 Method of treating immune pathologies with low dose estrogen
11/15/2001	CA2408889A1 Immunosuppressive compositions
11/15/2001	CA2408751A1 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity
11/15/2001	CA2408594A1 Human monoclonal antibodies to dendritic cells
11/15/2001	CA2408576A1 Rh116 polypeptides and its fragments and polynucleotides encoding said polypeptides and therapeutic uses
11/15/2001	CA2408571A1 Mammalian receptor proteins; related reagents and methods
11/15/2001	CA2408549A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408547A1 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells
11/15/2001	CA2408486A1 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
11/15/2001	CA2408319A1 Cxcr4 antagonist treatment of hematopoietic cells
11/15/2001	CA2408297A1 Cancer diagnosis and assays for screening anti-cancer agents
11/15/2001	CA2408213A1 Protein complexes and assays for screening anti-cancer agents
11/15/2001	CA2408002A1 Enzymatic assays for screening anti-cancer agents
11/15/2001	CA2407897A1 Molecular antigen arrays and vaccines
11/15/2001	CA2407865A1 Novel eosinophil cationic proteins used in the treatment of asthmatic and allergic disorders
11/15/2001	CA2407852A1 Ortho-substituted anthranilic acid amides and their use as medicaments
11/15/2001	CA2407850A1 Cytoskeleton-associated proteins
11/15/2001	CA2407830A1 Amino acid derivatives and their use as medicines
11/15/2001	CA2407817A1 Anthranilamides and their use as pharmaceutical agents
11/15/2001	CA2405968A1 Hydantoin derivatives with affinity for somatostatin receptors
11/15/2001	CA2379088A1 Treatment of il-10 deficiencies
11/14/2001	EP1154019A2 G-protein coupled receptor (HFGAN72X)
11/14/2001	EP1153931A1 Shortened-chain polynucleotides and process for the preparation thereof
11/14/2001	EP1153924A2 Substituted 1,3-oxathiolanes with antiviral properties
11/14/2001	EP1153611A2 Pharmaceutical composition for the treatment of fibrosis
11/14/2001	EP1153297A2 ASSAY FOR THE IDENTIFICATION OF IgE ANTIBODY SUPPRESSORS
11/14/2001	EP1153123A2 Pluripotential cells-2
11/14/2001	EP1153121A2 Secreted proteins and polynucleotides encoding them
11/14/2001	EP1153038A1 Therapeutics and diagnostics based on a il-1b mutation
11/14/2001	EP1153013A2 5-ht1f agonists
11/14/2001	EP1152776A1 Biodegradable, injectable oligomer-polymer composition
11/14/2001	EP1152771A2 Adjuvant and cell maturation agent
11/14/2001	EP1152770A1 Small peptides and methods for treatment of asthma and inflammation
11/14/2001	EP1152759A2 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR
11/14/2001	EP1152752A1 Methods for preventing graft rejection and ischemia-reperfusion injury
11/14/2001	EP0777482B1 Combined preparation for the therapy of immune diseases
11/14/2001	EP0763037B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USE THEREOF
11/14/2001	EP0722322B1 Compounds, compositions and treatment of allergies and inflammation therewith
11/14/2001	EP0715653B1 Humanised antibodies
11/14/2001	EP0672041B1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
11/14/2001	CN1322249A Neiseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
11/14/2001	CN1322210A High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one
11/14/2001	CN1322202A Quinazoline derivatives
11/14/2001	CN1322194A Substituted phenyl derivatives, their preparation and use
11/14/2001	CN1322193A Unsaturated hydroximic acid derivatives as PARP inhibitors
11/14/2001	CN1321771A Novel polypeptide-human dihydroorotase 17 and polynucleotide for coding this polypeptide
11/14/2001	CN1321768A Novel polypeptide-human ATP-dependent serine proteolytic enzyme 21 and polynucleotide for coding this polypeptide
11/14/2001	CN1321745A Macrophage inflammatory protein -3, -4 and -1 gamma
11/14/2001	CN1321678A Novel polypeptide-human kruppel related DNA bindin 42 and polynucleotide for coding this polypeptide
11/14/2001	CN1321677A Novel polypeptide-human Pax protein 11.9 and polynucleotide for coding this polypeptide
11/14/2001	CN1321676A Novel polypeptide-human NPAT protein 12 and polynucleotide for coding this polypeptide
11/14/2001	CN1321674A Novel polypeptide-human NPAT protein 15 and polynucleotide for coding this polypeptide
11/14/2001	CN1321656A Novel polypeptide-human Pax protein 11 and polynucleotide for coding this polypeptide
11/14/2001	CN1321654A Novel polypeptide-human pax protein 11.4 and polynucleotide for coding this polypeptide
11/14/2001	CN1321639A Substd. heterocyclic compounds, preparing process thereof and pharmaceutical composition contg them
11/14/2001	CN1321634A Substd heterocyclic compounds preparing method thereof and pharmaceutical composition contg. them
11/14/2001	CN1321479A Chinese medicine preparation for curing hematopathy
11/13/2001	US6316485 1,5-diphenylpyrazole derivatives
11/13/2001	US6316478 IL-8 receptor antagonists
11/13/2001	US6316475 Treatment of cancer, asthma, heart diseases, seizures, inflammation
11/13/2001	US6316472 Heterosubstituted pyridine derivatives as PDE 4 inhibitors
11/13/2001	US6316471 Treating inflammatory or autoimmune diseases
11/13/2001	US6316464 P38 MAP kinase inhibitors
11/13/2001	US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001	US6316444 SRC kinase inhibitor compounds
11/13/2001	US6316256 Method for protein transfer
11/13/2001	US6316239 HKABY60 kinase family polypeptides
11/13/2001	US6316227 Dna sequence encoding a composite heavy chain of a recombinant antibody molecule that specifically binds human interleukin-5 antigen
11/13/2001	US6316009 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharamaceutical and cosmetic compositions containing same
11/13/2001	US6316007 Combined physical and immunotherapy for cancer
11/13/2001	US6316002 Germination activated red Ganoderma lucidum spores and method for producing the same
11/13/2001	US6315998 Administering anti-cd40 monoclonal antibody or an antigen binding fragment which is being free of significant agonistic activity and binding to a human cd40 antigen located on surface of a human b cell prevents growth or differentiation
11/11/2001	CA2308105A1 Treatment of il-10 deficiencies
11/08/2001	WO2001084149A2 Diagnostics and therapeutics for macular degeneration-related disorders
11/08/2001	WO2001083785A2 Regulated antigen delivery system (rads) involving bacteria
11/08/2001	WO2001083782A2 Novel proteases
11/08/2001	WO2001083775A2 Proteases
11/08/2001	WO2001083772A1 Splice variant of camp phosphodiesterase type 7 (pde7a3)
11/08/2001	WO2001083755A2 Human anti-cd40 antibodies and methods of making and using same
11/08/2001	WO2001083750A2 Dendritic cell co-stimulator molecules
11/08/2001	WO2001083740A2 Splice-region antisense composition and method
11/08/2001	WO2001083724A1 A new polypeptide - human dihydrooratase 17 and the polynucleotide encoding it
11/08/2001	WO2001083698A2 Compositions and methods for inducing activation of dendritic cells
11/08/2001	WO2001083692A2 Recombinant aav vectors with aav5 capsids and aav5 vectors pseudotyped in heterologous capsids
11/08/2001	WO2001083560A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
11/08/2001	WO2001083554A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083547A2 Anti-inflammatory compounds and uses thereof
11/08/2001	WO2001083525A2 Modified peptides, comprising an fc domain, as therapeutic agents

1 ... 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 ... 1172